Technical and interpretive problems of peripheral nerve stimulation in monitoring neuromuscular blockade in the intensive care unit

Annals of Pharmacotherapy

Volumn 30, Issue 2, 1996, Pages 165-172

  Rudis, Maria I ^a,b   Guslits, Benjamin G ^a,c   Zarowitz, Barbara J ^a,d  

^a HENRY FORD HOSPITAL   (United States)

^b MEMORIAL HERMANN HOSPITAL   (United States)

^c Department of Anesthesia

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT;

BIOLOGICAL MONITORING; HUMAN; INTENSIVE CARE UNIT; MOTOR NEUROPATHY; NERVE CONDUCTION; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; PARALYSIS; PRIORITY JOURNAL; REVIEW;

EID: 0030021238     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000211     Document Type: Review

References (45)

1. Davidson JE. Neuromuscular blockade: indications, peripheral nerve stimulation, and other concurrent interventions. New Horiz 1994;2:75-84.
2. Watling SM, Dasta JF. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature. Crit Care Med 1994,2:34-47.
3. Op de Coul AAW, Lambregts PCLA, Koeman J, van Puyenbroek M, Laak H, Gabreels-Festen A. Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985;87:17-22.
4. Hoyt JW. Persistent paralysis in critically ill patients after the use of neuromuscular blocking agents in critical care. New Horiz 1994;2:48-55.
5. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992;327:524-8.
6. Isenstein DA, Venner DS, Duggan J. Neuromuscular blockade in the intensive care unit. Chest 1992;102:1258-66.
7. Report of the Anesthesia Drugs Advisory Panel. Bethesda, MD: US Food and Drug Administration, 1992.
8. Package insert. Norcuron (vecuronium). West Orange, NJ: Organon, 1994.
9. Package insert. Pavulon (pancuronium). West Orange, NJ: Organon, 1994.
10. Package insert. Tracrium (atracurium). Research Triangle Park, NC: Burroughs Wellcome, 1994.
11. Viby-Mogensen J. Neuromuscular monitoring. In: Miller RD, ed. Anesthesia. 6th ed. New York: Churchill Livingtone, 1994:1345-61
12. Griffin D, Fairman N, Coursin DB, Rawsthorne L, Grossman JE. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 1992;102:510-4.
13. Waclawik AJ, Sufit RL, Beinlich BR, Schutta HS. Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium Neuromusc Disord 1992;2:19-26.
14. Darrah WC, Johnston JR, Mirakhur RH. Vecuronium infusions for prolonged muscle relaxation in the intensive care unit. Crit Care Med 1989;17:1297-300.
15. Smith CL, Hunter JM, Jones RS. Vecuronium infusions in patients with renal failure in an ITU. Anaesthesia 1987;42:387-93.
16. Frankel H, Jeng J, Tilly E, S Andre A. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit (abstract). Crit Care Med 1994;22(1):A94.
17. Wymore ML, Eisele JH. Differential effects of d-tubocurarine on inspiratory muscles and two peripheral muscle groups in anesthetized man. Anesthesiology 1978;48:360-2.
18. Hudes E, Lee KC. Clinical use of peripheral nerve stimulators in anaesthesia. Can J Anaesth 1987;34:525-34.
19. Engbaek J, Skovgaard T, Friis B, Kann T, Viby-Mogensen J. Monitoring of neuromuscular transmission by electromyography (II). Acta Anaesthesiol Scand 1993;37:788-98.
20. Engbaek J, Skovgaard T, Friis B, Kann T, Viby-Mogensen J. Monitoring of the neuromuscular transmission by electromyography (I). Acta Anaesthesiol Scand 1993;36:495-504.
21. Dulin PG, Williams CJ. Monitoring and preventive care of the paralyzed patient in respiratory failure. Crit Care Clin 1994;10:815-26.
22. Prielipp RC, Coursin DB. Applied pharmacology of common neuromuscular blocking agents in critical care. New Horiz 1994;2:34-47.
23. Witt NJ, Zochodne DW, Bolton CF, Grand Maison F, Wells G, Young BG, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99:176-84.
24. Ali HH, Savarese JJ. Monitoring neuromuscular function. Anesthesiology 1976;45:216-49.
25. Ali HH. Monitoring of neuromuscular function and clinical interaction. Clin Anesthesiol 1985;3:447-65.
26. Bragg P, Fisher DM, Shi J, Donati F, Meistelman C, Lau M, et al. Comparison of twitch depresession of the adductor pollicis and the respiratory muscles. Anesthesiology 1994,80:308-19.
27. Heier T, Caldwell JE, Eriksson LI, Sessler DT, Miller RD. The effect of hypothermia on adductor pollicis twitch tension during continuous infusion of vecuronium in isoflurane-anesthetized humans. Anesth Analg 1994;78:312-7
28. Heier T, Caidwell JE, Sessler DI, Kitts JB, Miller RD. The relationship between adductor pollicis twitch tension and core, skin, and muscle temperature during nitrous oxide-isoflurane anesthesia in humans. Anesthesiology 1989;71:381A
29. Heier T, Caldwell JE, Harma ML, Gruenke LD, Miller RD. Mild intraoperative hypothermia does not change the pharmacodynamics (concentration-effect relationship) of vecuronium in humans. Anesth Analg 1994;78:973-7.
30. Miller RD, Agoston S, van der Pol F, Booij LH, Crul JF. Hypothermia and the pharmacokinetics and pharmacodynamics of pancuronium in the cat. J Pharamcol Exp Ther 1978;207:532-8.
31. Ham J, Miller RD, Benet LZ, Matteo RS, Roderick LL Pharmacokinetics and pharmacodynamics of d-tubocurarine during hypothermia in the cat. Anesthesiology 1978;49:324-9.
32. Ham J, Stanski DR, Newfield P, Miller RD. Pharmacokinetics and dynamics of d-tubocurarine during hypothermia in humans. Anesthesiology 1981;55:631-5.
33. Cook DR, Freeman JA, Lai AA, Kang Y, Stiller RL, Aggarwal S, et al. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal disease. Br J Anaesth 1992;69:580-5.
34. Ostergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand 1992;36:702-6.
35. Devlin JC, Head-Rapson AG, Parker CJR, Hunter JM. Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis. Br J Anaesth 1993;71:227-31.
36. Bevan DR. Prolonged mivacurium-induced neuromuscular block. Anesth Analg 1993;77:4-6
37. Bolton CF. Neuromuscular abnormalities in critically ill patients. Intensive Care Med 1993;19:309-10.
38. Berger JJ, Gravenstein JS, Munson ES. Electrode polarity and peripheral nerve stimulation Anesthesiology 1982;56:402-24.
39. Kopman AF, Lawson D. Milliamperage requirements for supramaximal stimulation of the ulnar nerve with surface electrodes. Anesthesiology 1984;61:83-5.
40. Stiffel P, Hameroff SR, Blitt CD, Cork RC. Variability in assessment of neuromuscular blockade. Anesthesiology 1980;52:436-7.
41. Walts LF, Levin N, Dillon JB. Assessment of recovery from curare. JAMA 1970;213:1894-6.
42. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the diaphragm, orbicularis oculi and adductor pollicis muscles. Anesthesiology 1990;73:870-5.
43. Donati F, Antzaka C, Bevan DR. Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 1986;65:1-5.
44. Viby-Mogensen J, Jensen NH, Engbaek J, Ording H, Skovgaard LT, Chraemmer-Jorgensen B. Tactile and visual evaluation of the response to train-of-four stimulation. Anesthesiology 1985;63:440-3.
45. Howardy-Hansen P, Viby-Mogensen J, Gottschau A, Skovgaard LT, Chraemmer-Jorgensen B, Engbaek J. Tactile evaluation of the posttetanic count (PTC). Anesthesiology 1984;60:372-4.